This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universita' Degli Studi Di Catanzaro “Magna Graecia”. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Maria Fiammetta Romano: Innovator in Apoptosis Research
Introduction
Maria Fiammetta Romano is a notable inventor based in Naples, Italy. She has made significant contributions to the field of molecular biology, particularly in the study of apoptosis, or programmed cell death. Her work has implications for various physiological and pathological processes, including neoplasias and degenerative diseases.
Latest Patents
Maria Fiammetta Romano holds a patent for "Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis." This patent describes a nucleotide sequence and a corresponding protein that play a crucial role in regulating apoptosis. The applications of this invention extend to all processes involving cell death, including those related to tissue infarcts and autoimmune diseases.
Career Highlights
Throughout her career, Maria has been associated with prestigious institutions such as the Università Degli Studi di Catanzaro "Magna Graecia." Her research has contributed to a deeper understanding of the mechanisms underlying cell death and its regulation.
Collaborations
Maria has collaborated with esteemed colleagues, including Rita Bisogni and Annalisa Lamberti. Their joint efforts have further advanced the research in apoptosis and its related fields.
Conclusion
Maria Fiammetta Romano's innovative work in the field of apoptosis research highlights her significant contributions to science. Her patent and collaborations reflect her dedication to advancing our understanding of critical biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile